Parallax Volatility Advisers’s Anika Therapeutics ANIK Stock Holding History

Parallax Volatility Advisers’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,351	Closed	-$1.21M	–	2443
2019 Q4	$1.21M	Buy	23,351 +3,715	+19%	+$216K	﹤0.01%	1448
2019 Q3	$1.08M	Sell	19,636 -16,615	-46%	-$853K	﹤0.01%	1350
2019 Q2	$1.47M	Buy	36,251 +35,174	+3,266%	+$1.28M	﹤0.01%	1149
2019 Q1	$33K	Buy	+1,077	New	+$36.9K	﹤0.01%	2443
2018 Q4	–	Sell	-1	Closed	–	–	2880
2018 Q3	$0	Sell	1 -2,938	-100%	-$116K	﹤0.01%	2542
2018 Q2	$94K	Buy	+2,939	New	+$121K	﹤0.01%	1481
2018 Q1	–	Sell	-2,184	Closed	-$118K	–	2208
2017 Q4	$118K	Buy	+2,184	New	+$121K	﹤0.01%	2694

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Parallax Volatility Advisers's ANIK Position: Q1 2020 in Review

Parallax Volatility Advisers sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 23,351 shares — an estimated $1.21M sold.

Parallax Volatility Advisers first reported a position in ANIK in Q4 2017 and held it in 7 quarters. The position peaked at $1.47M in Q2 2019. 163 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

Parallax Volatility Advisers reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
Parallax Volatility Advisers sold 23,351 Anika Therapeutics shares in Q1 2020, an estimated $1.21M.
Parallax Volatility Advisers first reported a position in Anika Therapeutics in Q4 2017 and held it in 7 quarters.
Parallax Volatility Advisers's Anika Therapeutics position peaked at $1.47M in Q2 2019.
163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on Parallax Volatility Advisers's 13F filing for Q1 2020, filed 15 May 2020.